- Home
- SNDX vs XPRO Comparison
SNDX vs XPRO Comparison
Compare SNDX & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- XPRO
- Stock Information
- Founded
- SNDX 2005
- XPRO 1938
- Country
- SNDX United States
- XPRO United States
- Employees
- SNDX N/A
- XPRO N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- XPRO Oilfield Services/Equipment
- Sector
- SNDX Health Care
- XPRO Energy
- Exchange
- SNDX Nasdaq
- XPRO Nasdaq
- Market Cap
- SNDX 1.1B
- XPRO 1.3B
- IPO Year
- SNDX 2016
- XPRO 2013
- Fundamental
- Price
- SNDX $13.08
- XPRO $14.83
- Analyst Decision
- SNDX Strong Buy
- XPRO Buy
- Analyst Count
- SNDX 10
- XPRO 3
- Target Price
- SNDX $36.20
- XPRO $23.33
- AVG Volume (30 Days)
- SNDX 2.6M
- XPRO 1.4M
- Earning Date
- SNDX 02-25-2025
- XPRO 02-19-2025
- Dividend Yield
- SNDX N/A
- XPRO N/A
- EPS Growth
- SNDX N/A
- XPRO 685.47
- EPS
- SNDX N/A
- XPRO 0.14
- Revenue
- SNDX $16,000,000.00
- XPRO $1,682,709,000.00
- Revenue This Year
- SNDX N/A
- XPRO $16.21
- Revenue Next Year
- SNDX $14.15
- XPRO $4.27
- P/E Ratio
- SNDX N/A
- XPRO $103.24
- Revenue Growth
- SNDX N/A
- XPRO 15.49
- 52 Week Low
- SNDX $12.06
- XPRO $10.71
- 52 Week High
- SNDX $25.34
- XPRO $24.50
- Technical
- Relative Strength Index (RSI)
- SNDX 41.29
- XPRO 75.58
- Support Level
- SNDX $12.40
- XPRO $13.52
- Resistance Level
- SNDX $13.16
- XPRO $14.78
- Average True Range (ATR)
- SNDX 0.65
- XPRO 0.50
- MACD
- SNDX 0.10
- XPRO 0.30
- Stochastic Oscillator
- SNDX 39.38
- XPRO 99.55
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About XPRO Expro Group Holdings N.V.
Expro Group offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions, capabilities enhanced by the 2021 merger with Frank's International. It also provides production optimization for both onshore and offshore applications. The majority of its business relies on international and offshore markets, representing about 80% and 70% of annual revenue, respectively.